(Q39528150)

English

Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch.

scientific article published on September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

0 references

Carmine Tinelli

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Francesco Castelli

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

L R Tomasoni

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

A Patroni

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

C Torti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

G Paraninfo

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

F Gargiulo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

E Quiros-Roldan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

M C Uccelli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

P Airò

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

G Carosi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Brescia-MASTER Study Group

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

311-323

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

CD4 cell counts at the third month of HAART may predict clinical failure.

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Decreased HIV-associated T cell apoptosis by HIV protease inhibitors.

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Impaired replication of protease inhibitor-resistant HIV-1 in human thymus.

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Repeated measures in clinical trials: simple strategies for analysis using summary measures

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

High levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapy

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310%2FFGMF-Y0LY-DMX8-371V

21 January 2018

Identifiers

10.1310/FGMF-Y0LY-DMX8-371V

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14583847%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39528150&oldid=1460649452"